THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $185,650,000 | +47.2% | 17,613,872 | +0.3% | 0.02% | +38.9% |
| Q3 2015 | $126,146,000 | -60.2% | 17,569,014 | +0.2% | 0.02% | -56.1% |
| Q2 2015 | $316,783,000 | +15.1% | 17,530,909 | +0.2% | 0.04% | +17.1% |
| Q1 2015 | $275,125,000 | +13.8% | 17,501,620 | +2.4% | 0.04% | +12.9% |
| Q4 2014 | $241,787,000 | -5.6% | 17,087,423 | +14.0% | 0.03% | -11.4% |
| Q3 2014 | $256,071,000 | -27.0% | 14,983,664 | +27.3% | 0.04% | -25.5% |
| Q2 2014 | $350,587,000 | +12.6% | 11,772,557 | +17.0% | 0.05% | +9.3% |
| Q1 2014 | $311,250,000 | -19.2% | 10,059,816 | -6.9% | 0.04% | -20.4% |
| Q4 2013 | $385,013,000 | -21.1% | 10,799,816 | -9.5% | 0.05% | -28.0% |
| Q3 2013 | $487,707,000 | +13.1% | 11,927,287 | +6.5% | 0.08% | +5.6% |
| Q2 2013 | $431,361,000 | – | 11,195,459 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |